
- BioPharm International-03-15-2018
- Volume 2018 eBook
- Issue 1
Choosing an Analytical Partner in Early Drug Development
Successful outsourcing relationships for early phase analytics in drug development are driven by partnership.
Criteria for choosing an analytical services partner during the early phase of drug development include scientific skills/knowledge and resource availability, and the type of relationship developed with an analytical service provider is typically defined by customer needs. To start with, the provider of early phase analytical studies should show that they have the necessary scientific skills and knowledge to support the program in question. Discussions between client and provider are also necessary to ensure that both parties are comfortable with what is required out of the relationship.
View other articles in
Article Details
BioPharm International
eBook: Outsourcing Resources 2018
Vol. 31
March 2018
Pages: 27–29
Citation
When referring to this article, please cite it as F. Mirasol, " Choosing an Analytical Partner in Early Drug Development," BioPharm International Outsourcing Resources eBook (March 2018).
Articles in this issue
over 7 years ago
Quality Oversight During Sterile Filling Operationsover 7 years ago
Good Quality Agreements Support Compliance with CGMPover 7 years ago
Gaining Analytical Insight in the Development of Biologicsover 7 years ago
Contract Services Investment Updateover 7 years ago
Process Validation in Biologics Developmentover 7 years ago
Bigger is Better in Samsung's Approach to Biomanufacturingover 7 years ago
Outsourcing: Does Focus Pay Off?over 7 years ago
Avoiding Complete Response LettersNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.